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Ab s t r a c t 
 
Purpose: Although information on variations in health service performance is now more widely 
available, relatively little is known about how healthcare payers use this information to improve resource 
allocation. We explore to what extent and how Primary Care Trusts (PCTs) in England have used the 
NHS Atlas of Variation in Healthcare, which has highlighted small area variation in rates of expenditure, 
activity and outcome. 
 
Methods: Data collection involved an email survey among PCT Chief Executives and a telephone 
follow-up to reach non-respondents (total response: 53 of 151 of PCTs, 35%). 45 senior to mid-level staff 
were interviewed to probe themes emerging from the survey. The data were analysed using a matrix-
based Framework approach. 
 
Findings: Just under half of the respondents (25 of 53 PCTs) reported not using the Atlas, either because 
they had not been aware of it, lacked staff capacity to analyse it, or did not perceive it as applicable to 
local decision-making. Among the 28 users, the Atlas served as a prompt to understand variations and as 
a visual tool to facilitate communication with clinicians. Achieving clarity on which variations are 
unwarranted and agreeing on responsibilities for action appeared to be important factors in moving 
beyond initial information gathering towards decisions about resource allocation and behaviour change. 
 
Conclusions: Many payers were unable to use information on small area variations in expenditure, 
activity and outcome. To change this what is additionally required are appropriate tools to understand 
causes of unexplained variation, in particular unwarranted variation, and enable remedial actions to be 
prioritised in terms of their contribution to population health. 
1. Introduction 
Over the past 40 years, medical variation research has largely focused on the identification and 
measurement rather than the management of variations in healthcare. Studies in particular from North 
America and increasingly also from other countries show that medical practice varies across regions, and 
that the magnitude of these variations cannot solely be explained by differences in demographic and 
illness profiles of regional populations [1–4]. Evidence of substantial variations in medical practice thus 
challenges the core societal objective of many health systems to provide equal access to safe and effective 
health care for equal need [5,6]. But while healthcare payers now have unprecedented access to data about 
variations in health service utilisation and performance, there is little research on how payers might 
actually use this data to improve resource allocation and outcomes. Studies so far have focused on shared 
decision making [7,8] and behaviour change interventions at a hospital level [9–11].  
 
However, the ways in which regional variations data might inform resource allocation at a population 
level by those responsible for the management of the system, have not been explored. In this article we 
ask how a healthcare payer in charge of planning and purchasing health services for a geographical 
population might move from data awareness to decisions to improve quality and value in healthcare. 
Realising this basic quest may not be straightforward, as Glasziou and Haynes [12] point out in the 
context of guideline implementation, because the path from research to improved outcomes poses a series 
of hurdles to clinical and managerial decision-makers. Prior to acting on the research findings, they need 
to be aware of and accept the data, perceive the data as applicable to their situation, and be able to use the 
data. These barriers seem pertinent to research use in general [13]. Data on medical practice variations 
create the additional conundrum that, as opposed to a guideline, they rarely tell the user what to do.  
 
There appear to be two general pathways for taking action on medical practice variation. The two 
principal aims of performance indicator systems stated in the literature relate to internal and external 
control and accountability [14,15] and formative learning [16,17]. Similarly, Carter et al. [18] distinguish 
between “dials” that show achievement against targets, and “tin openers” that simply indicate potential 
problems and then lead to in-depth analysis and action. For both types of indicators, action would require 
agreement on who is responsible for leading investigation and change, and how to identify and remedy 
the causes underlying those identified variations. A key feature of classic variations research, as presented 
in Atlases of Variation [19–21], is however the essential ambiguity over the meaning of observed 
variations. Generally this data does not allow for direct inferences from relative rates of activity to good 
or bad performance of the entities under investigation. As optimal performance is not identified, this data 
thus differs from benchmarking where all organisations are compared with the ‘best’ performer [22]. In 
this case, geographic variations data is likely to serve as a “tin opener” rather than as a “dial”. As Evans 
[5] pointed out, dealing with the uncertainty how to address practice variations would thus first require 
defining and operationalising which part of the observed variations, if any, is unwarranted.  
 
Fig. 1 suggests a model to frame the process of translating evidence of geographic variations into 
decisions to shape resource allocation and planning. This model comprises two main stages. The first 
stage is informed by the literature on guideline implementation [12] and research use [13] and consists of 
a series of prerequisites for staff in a healthcare purchasing organisation to be in a position to use such 
evidence: that they are aware of its existence, trust the information it provides, can see its relevance to 
them and are capable of using this information. The second stage is structured around the pathway for 
using the information [5]: identifying unwarranted variation; agreeing who will be responsible for action; 
identifying causes and appropriate remedies; and making decisions on resource allocation. 
 
This model frames the questions our research sought to answer. As a case study we used the NHS Atlas 
of Variation in Healthcare, which in its first edition from November 2010 highlighted variation in 
expenditure, activity and outcomes across a wide range of clinical areas at the level of Primary Care 
Trusts (PCTs), the local payers in England [20]. Our aim was to examine: (1) the extent to which PCTs 
met the prerequisites for using the NHS Atlas; and (2) how they were using the NHS Atlas in local 
decision making. We emphasise that most of this study was done before the publication of the second 
edition of the Atlas. We would expect awareness and capacity to use information on variations to increase 
over time and see this study as helping with both. 
 
 
2. Materials and methods 
2.1. Setting 
At the time of study (July 2011–March 2012), the planning and delivery of health services in the National 
Health Service (NHS) in England was entrusted to 151 PCTs. They received a fixed financial allocation 
for their local populations (median size 284,000, ranging from under 100,000 to over one million people 
[23]) with reference to a national resource allocation formula, that aimed to estimate an equitable 
distribution of funds against needs across the country [24]. Within allocated resources, PCTs were 
responsible for: improving health and reducing health inequalities, securing access to comprehensive, 
effective and efficient services, and appropriately responding to needs of their populations. They were 
responsible for commissioning health services across all service sectors (public health, primary care 
services including dentistry, pharmacy and optometry, community health services, social care, mental 
health, elective and acute hospital care) and were required to engage in [25,26]: 
 
1) Strategic planning: assessing needs, reviewing service provision, deciding priorities. 
2) Procuring services: designing services, shaping the structure of supply, managing demand for 
services. 
3) Monitoring and evaluation: supporting patient choice, managing performance, seeking public 
and patient views. 
 
The English NHS at the time of study was under expenditure constraints and required to generate 
efficiency savings of about 4% of total annual resources every year between 2011 and 2015, in order to 
meet rising demand for health services [27]. The proposed organisational reform outlined in the 
government White Paper Equity and Excellence: Liberating the NHS of July 2010 [28], entailed the 
abolition of PCTs in April 2013, to be succeeded by general practitioner-led clinical commissioning 
groups. Thus, although information on variations has potential to help managers understand 
and focus on areas for efficiency savings in their local health economy, to be invested in areas of higher 
value, PCTs were likely to be distracted by their looming abolition. 
 
Fig. 1. A framework for moving from data on geographic variations to resource allocation decisions. 
 
 
Sources: adapted from [5,12]. 
2.2. The NHS Atlas of Variation in Healthcare 
Since Glover’s seminal study on variation in tonsillectomy rates among British school children in 1938 
[29], research has repeatedly documented regional variation in medical practice in England [3,30–34]. 
Our focus was specifically on the NHS Atlas of Variation in Healthcare, because this Atlas for the first 
time highlighted variation in expenditure, activity and outcome across a large range of clinical areas at 
PCT level and was thus likely to be particularly relevant within a commissioning context. Inspired by the 
U.S. Dartmouth Atlas, the NHS Atlas was developed by the Department of Health’s national Quality, 
Innovation, Productivity and Prevention (QIPP) programme, a large scale transformational programme 
intended to address these four major challenges confronting the NHS [27], through the Right Care 
workstream. The first NHS Atlas, published in November 2010 [20], consists of 34 maps of variation 
(2011 Atlas: 71 maps [35]). These maps represent the relative position of PCTs in quintiles across 
selected indicators, standardised for age and sex. The topics were selected in consultation with the 
National Clinical Directors as being of importance to their clinical specialty; for instance in terms of 
volume, cost, patient outcomes, or recent trends in delivery patterns. 
 
The NHS Atlas was primarily targeted at those who manage and allocate resources for healthcare; 
commissioners and clinicians. Its objective was to provide information in ways that would stimulate local 
investigation into unwarranted variation in the NHS, its underlying causes, and remedial action. Given the 
complexity and variety of the different kinds of variations reported in the NHS Atlas, there was neither 
ranking nor evaluation of the performance of NHS organisations; nor are there any links with (external) 
financial incentives. This differs from NHS star ratings (2000–2005), and the Annual Health Check 
(2006–2009) which gave annual summative aggregate scores of performance [36]; and more recent care 
quality targets that clearly define successful achievement [37]. The NHS Atlas carefully avoids rating 
PCTs as ‘good’ or ‘bad’ performers based on high, middle or low indicator values. Targets or ‘optimal’ 
rates of activity are not defined. However, in the wide-ranging media echo to the NHS Atlas, several think 
tanks, academics, charities and politicians interpreted the magnitude of regional variations as indications 
of unwarranted variation, and urged PCTs and the government to take action [38–40]. 
 
2.3. Study design 
The first part of data collection involved an email survey with open-ended questions among the Chief 
Executives of all 151 PCTs. Given the low response (18 of 151 of PCTs, 12%), non-respondents were 
followed-up by telephone (total response: 53 of 151 of PCTs, 35%). The survey was designed to gain an 
indicative overview whether the Atlas was used, why or why not, in what form and by whom, and to 
identify interview partners. The second part of the research involved interviews based on a semi-
structured protocol, in order to probe themes emerging from the survey. 
 
Interviewees were chosen if they had used the Atlas or, if nobody in the organisation had used it, based on 
their job roles relevant to using such data. Both users and nonusers of the Atlas were interviewed as 
representatives of their organisations. If they were unsure whether others had used the NHS Atlas they 
asked other colleagues if they had. If at least one person reported using the NHS Atlas, the PCT was 
recorded as a ‘user’. A working definition of ‘use’ of the Atlas was that PCT staff reported some form of 
engagement with the material. Before the interviews, permission for tape-recording was obtained. In total, 
45 interviews with senior to mid-level executives involved in public health, commissioning and 
knowledge management from 29 PCTs were undertaken face-to-face or via telephone between October 
2011 and March 2012. The interviews were transcribed verbatim and, guided by the conceptual 
framework, reviewed iteratively with the survey results to identify and confirm emergent themes. Themes 
were analysed using the Framework approach [41], a matrix based method to construct and organise an 
index of central themes and subthemes, and thereby facilitate a synthesis of the findings by theme and by 
respondent. The recruitment of interviewees was stopped when a stage of saturation was reached; that is 
when no new themes emerged [42]. 
 
3. Results 
3.1. Prerequisites for using the NHS Atlas  
PCTs can be classified into four groups of ‘non-users’ (groups 1.1–1.4), according to the account they 
gave for not using the NHS Atlas, and ‘users’ (group 2). As the survey results (Fig. 2) suggest, the 
number of PCTs appears to decline along these stages from awareness to actual use. Emerging themes 
from the qualitative analysis (Table 1) point to possible underlying reasons, as reported by PCT staff.   
Most PCTs were aware of the NHS Atlas (44 of 53 PCTs, group 1.1). Those who had not been aware of 
the Atlas, despite it being distributed to all PCTs and the relatively large media echo following its 
publication, referred to being distracted by the structural reorganisation which reduced their attention to 
information about healthcare delivery.  
 
Group 1.2 was aware of and accepted the NHS Atlas data as generally valid and reliable, although several 
respondents cautioned about taking the data at face value. In contrast, staff in three PCTs perceived these 
regional comparisons not as credible due to differences in local management processes, for example in 
coding patterns, and some noted their preference to work with local data. All PCT respondents recognised 
unwarranted practice variations as a challenge. This challenge was frequently linked to the NHS-wide 
economic constraints and the need to meet rising demand with fewer resources. However, only 37 PCTs 
(group 1.3) perceived the Atlas as applicable to their local situation.  The main reasons for limited 
applicability were the difficulty of (i) inferring from observed variations what ought to be done along care 
pathways and (ii) discerning the relationship between relative rates of activity and absolute scale of 
impact on population health outcomes and total service expenditure. Six PCTs who viewed the NHS 
Atlas as applicable to local decision making noted organisational constraints to use. In particular, annual 
priorities for action had already been agreed prior to publication of the Atlas and PCTs lacked staff 
capacity to tackle new issues. Among 31 PCTs (group 1.4) who reported the capacity for using the Atlas, 
three PCTs had only recently been able to make this capacity available. These PCTs were planning to use 
the second NHS Atlas published in December 2011. Overall, at the time of study, just over half of the 
respondents (28 of 53 PCTs, group 2) had thus translated the perceived need to tackle regional variations 
into actual use of the NHS Atlas. 
 
 
Fig. 2. Survey responses to the NHS Atlas (n = 53 PCTs). 
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3.2. Using the NHS Atlas in local decision making 
Among the users (group 2; 28 of 53 PCTs), a first basic response to the NHS Atlas was to review all maps 
in order to gain an overview over the PCT’s relative position across a range of indicators. PCT staff 
seemed predominantly concerned to understand where they were ‘outliers’; indicators on which the PCT 
was in the highest or lowest quintile of rate of expenditure, activity or outcome relative to the national 
average. Qualitative themes on uses of the NHS Atlas in local decision making processes, and factors 
complicating and enabling its use, are illustrated in Table 1 and explained in more detail below.  
 
The initial interpretation of ‘outlier’ positions tended to be indicative rather than prescriptive. As 
respondents noted, the outliers shown in the NHS Atlas helped them to identify areas to focus on in their 
local health economy. Several interviewees referred to the concept of triangulation inasmuch as a view on 
variation complemented various other national and local sources of data (e.g. workforce, financial, 
activity and outcome data insofar as it was available). In their entirety, these multiple pieces of evidence 
could then help to frame strategic challenges for the PCT. As public health staff in twelve PCTs pointed 
out, the NHS Atlas supported learning about strategic problems both internally and externally with 
clinicians. While the Atlas sometimes confirmed existing local suspicions rather than providing new 
information to PCT staff, map-based visualisations did help to communicate this understanding to 
clinicians who were not familiar with the statistical data, thus placing it on the management agenda. 
Messages from the NHS Atlas were then locally disseminated through newsletters, the Annual Public 
Health report, integration into evidence-into-practice packages or presentations to clinicians. 
 
Beyond the description and illustration of variations, the evaluation of what were perceived as 
unwarranted variations appeared to be painstaking. As interviewees explained, they attempted to draw as 
much as possible on existing outcomes research and cost-effectiveness guidance. Further indications of 
unwarranted variations related to perverse incentives induced by payment systems, and hospital 
admissions perceived to be avoidable with timely diagnosis and treatment in primary care. For most 
PCTs, a position in the highest or lowest quintile served as but one indication of unwarranted variation, 
that was further explored with other data sources. In turn, however, many PCTs associated a position in 
the medium quintile with a lower priority for any action. In some PCTs, this was because a position 
around the national average was, implicitly, equated with an appropriate rate of activity. These PCTs 
appeared to take the NHS Atlas at face value, rather than as a prompt for further investigation. In other 
PCTs, in contrast, respondents conceded that limited staff capacity prevented them from exploring all 
possible sources of unwarranted variation. These respondents pointed out that, although a position in the 
medium quintile might not be optimal, they had decided to start exploring areas where they were outliers, 
relative to peers, because these areas might provide larger opportunities to reveal wasteful spending or 
perceived underinvestment. While PCT respondents confirmed the difficulty of defining and identifying 
unwarranted variation, they also pointed out that this challenge had to be considered within the wider 
problem of where they should start in improving resource allocation by investing limited funds more 
wisely in order to improve outcomes. 
 
Agreements on responsibilities for action appeared to be decisive in using variations data for local 
decision making. For the few target-like indicators in the NHS Atlas, where existing clinical guidance 
would stipulate preferably high values, six PCTs emphasised the importance of involving clinicians at an 
early stage, as they would ultimately allocate healthcare resources. In two PCTs, for example, maps 
of variation showing less than 30% of patients with diabetes had received nine key care processes, as 
opposed to over 70% in the ‘best’ PCT, helped to convince general practitioners that not only  
performance was unacceptably poor, in relative and absolute terms, but also that improvements were 
possible. PCT staff perceived the NHS Atlas as a “catalyst which motivated clinicians to take action 
sooner than they might have done otherwise” (Director of Commissioning, PCT22). 
 
Among the 28 PCTs where staff had reviewed the Atlas, 18 engaged in further in-depth analysis of 
possible causes underlying variation. An essential factor appeared to be leadership; both in terms of 
support from the executive management and local champions from the PCT and clinicians who took the 
analyses forward. The development of structures to use data on variations also appeared to be important. 
Some PCTs noted the increasing role of Priority Forums to engage multiple stakeholders in order to 
improve value, in terms of the relationship between expenditure and health outcomes, in resource 
allocation. At an operational level, these PCTs had also established regular meetings with providers from 
primary and secondary care, in order to agree local objectives for action and foster continuous monitoring 
and feedback against these objectives at hospital or practice levels. In contrast, in PCTs which did not 
report further action on the observed variations, interviewees also frequently noted a lack of Executive 
and Board level support, public health and analytical capacity to address the observed variations. 
 
Table 2 exemplifies some of the different logics for moving from variations data to in-depth analysis and 
decisions about resource allocation. An approach to understanding variations in high-level aggregate 
indicators, such as total spending on a disease area as in PCT A, was to break down the data into the 
underlying procedures and settings of care. The objective was to identify the specific drivers of 
expenditure in a local health economy. Understanding variations in activity involved the exploration of 
specific hypotheses regarding commissioning policies and supplier behaviour, as in PCTs B and C. 
Depending on the particular causes identified as underlying variations in practice, PCTs decided whether 
changes in planning, contracting or service design would be necessary. 
 
 
Table 1. Qualitative responses to the NHS Atlas 
 
Theme  Sub-theme  Example/illustration 
   
1.1. Awareness 
of the data 
Distraction due to 
organisational 
reforms 
“The development of CCGs [clinical commissioning groups, successors of 
PCTs as from April 2013] left little room for anything else, such as 
improving services . . . we were mainly concerned with getting the new 
structures going” 
(Chief Operating Officer, PCT4) 
1.2. Acceptance 
of the 
data 
Local management 
processes seen as too 
different 
“If you look at geographic differences in spending patterns, there may be 
distortions, in the ways costs are allocated . . . for example PCT spending on 
cancer may differ depending on the ways hospice costs are taken into 
account” 
(Director of Public Health, PCT7) 
 Preference to work 
with local data 
“I prefer to work with raw and more detailed local data, for many reasons. . . 
the data in the Atlas has been transformed and aggregated, which makes it 
sometimes difficult to understand what is in, and what is out . . . surely you 
can look up some of these issues in the meta-data [a file published by Right 
Care detailing the data sources and calculations of Atlas data] . . . but there 
is also the time lag of 1-2 years in the Atlas data, which is understandable as 
it takes time to do an Atlas, but at local level we have moved on since then, 
and have more recent data in some areas” 
(Information Analyst, PCT14) 
1.3. Perceived 
applicability of 
the data 
Single indicators 
versus pathways of 
care 
“The Atlas is rather narrow in its focus on single indicators . . . what does 
this mean for the entire pathway, from community, primary to hospital care . 
. . is this variation in a single indicator actually meaningful, what does it 
mean for the pathway?” 
(Public Health Analyst, PCT3) 
1.3. Perceived 
applicability of 
the data 
Other criteria besides 
the magnitude of 
variation 
“Looking at variations only can be misleading if you want to improve 
services. There may be large scope for improvement even for those in the 
top quintile nationally. Then of course some areas are simply too difficult to 
improve. So it’s not just about reducing variations but about where to start if 
you want to improve population health” 
(Director of Public Health, PCT6) 
“What I want to know is: where do we have the largest potential for 
efficiency savings, that don’t harm patients . . . the Atlas alone can’t tell me 
that” 
(Financial Director, PCT12) 
1.4. Ability to use 
the data 
No staff capacity to 
use NHS Atlas 
“We had already agreed priorities for action when the Atlas was published, 
and had no further resources and analysts to tackle new issues” 
(Medical Adviser, PCT9) 
2. Use of the Strategic problem “Surely the Atlas alone is not enough but we use it to triangulate with other 
NHS Atlas framing evidence. This helps us to see where we have most potential to improve, 
mainly financially” 
(Head of Performance, PCT5) 
 Problem 
communication 
“The maps often confirmed our existing local suspicions. But they helped a 
lot to illustrate to GPs [general practitioners] where we stand compared to 
other PCTs” 
(Public Health Analyst, PCT13) 
“We used the Atlas to visualise problems to clinicians, in an accessible 
format . . . this in turn served as a catalyst which motivated clinicians to take 
action sooner than they might have done otherwise” 
(Director of Commissioning, PCT1) 
Challenges in 
using the 
NHS Atlas 
Unclear basis for 
evaluating 
‘unwarranted’ 
variation 
“There is not always a clear-cut definition what variation is bad... usually we 
take NICE [National Institute for Health and Clinical Excellence] guidance 
as a basis, if it is available for this area” 
(Public Health Analyst, PCT1) 
“Variation is “unwarranted” for us if we could have avoided it with better 
organisation of the service, or better provider payment... but my concern is 
that we don’t always know what better payment or delivery should look 
like” 
(Commissioning staff, PCT2) 
 Role of the national 
average as an implicit 
reference point 
“We were in the middle for most indicators . . . so nothing alarming really” 
(Medical Adviser, PCT24) 
“It’s difficult to know where to start . . . we also don’t have the resources to 
do everything. So we mainly looked at areas where we were large outliers . . 
. if you are very different from others, it’s likely that something goes wrong 
in your PCT. But for respiratory disease we are around the national average 
for most indicators in the Atlas and still I think we could improve a lot” 
(Public Health Analyst, PCT2) 
Enabling factors 
for coordinating 
further analysis 
and action 
(Internal) 
responsibilities for 
action: Management 
structures and clinical 
involvement 
“We have regular performance management meetings together with local 
clinicians to agree service objectives, and who does what . . . and then we 
monitor progress towards these objectives. The Atlas fit in naturally into our 
existing structures” 
(Director of Commissioning, PCT16) 
“It’s key to have some structures to get local clinicians on board, to have a 
team that visits the practices, talks to clinicians . . . asking them regularly 
about variations and why this local health economy might differ from 
others” 
(Director of Commissioning, PCT25) 
 Leadership and high-
level support 
“The PCT Board gave great support in using the Atlas . . . they discussed the 
Atlas at one of the Board meetings, and appointed a person to champion 
work into variations” (Public Health 
Analyst, PCT21) 
Table 2. Case studies. 
 PCT A PCT B PCT C 
Data from the NHS Atlas PCT A was in the highest 
national quintile for total 
spending on cancer care 
PCT B was in the highest 
national quintile for rates 
of cataract surgery 
PCT C was in the highest 
national quintile for 
magnetic resonance 
imaging [MRI] activity 
Evaluating unwarranted 
variation and its causes 
NHS Atlas data was 
disaggregated using data 
from the regional Quality 
Observatory: from total 
spending at regional level 
to patterns of spending 
across procedures and 
across settings of care 
The cancer care team 
identified two main drivers 
of unwarranted variation: 
1. Multiple charging for 
treatment events due to 
four separate charges for 
chemotherapy 
2. High levels of  
emergency admissions 
both at active treatment 
stage and at the end of life 
Comparisons with 
neighbouring PCTs 
showed a lower clinical 
threshold for cataract 
surgery in PCT B (6/12 
versus 6/9 in the worse 
eye) 
Reasoning about  
unwarranted variations 
was based on two main 
observations: 
1. The current clinical 
threshold was at the lower 
end of the driving standard 
set by the Driver and 
Vehicle Licensing Agency 
(between 6/9 and 6/12) 
2. A large national audit 
had shown that one in 
three eyes with a pre-
operative visual acuity of 
6/9 either had no benefit or 
a poorer outcome post-
operatively. In eyes with a 
pre-operative visual acuity 
of 6/12, only one in eight 
did not improve 
 
In one of the regular 
performance management 
meetings between PCT 
staff and hospital medical 
and operating managers, 
clinician discretion was 
identified as a likely driver 
of variation A 
retrospective audit was 
undertaken to compare 
clinical guideline 
recommendations with 
actual practice. The audit 
showed clinicians 
complied with current 
guidance in prompting the 
provision of MRIs 
Responsibilities for action Monitoring by the PCT 
and regular performance 
meetings between the 
Director of 
Commissioning and local 
physicians 
Review by the PCT’s 
public health team as a 
basis for review by the 
PCT’s Priorities Forum 
Joint leadership by the 
PCT’s commissioning 
team, the medical director 
and operating officer of 
the acute hospital 
Analysis and decisions on 
actions 
Cancer-care specific 
decisions included: 
1. The revision of 
contracts to ensure 
appropriate payment 
2. Commissioning of new 
community services 
The Priorities Forum 
(which advises the PCT on 
the treatments that should 
be given high or low 
priority and comprises 
public health and 
commissioning staff, 
primary and secondary 
Current practice and 
relatively high rates of 
MRI utilisation were 
considered to be 
appropriate 
including Palliative Care 
Co-ordination and Rapid 
Response Teams to 
decrease the burden on 
hospital emergency 
facilities 
care representatives, a lay 
representative and a 
librarian) agreed: 
1. to increase the clinical 
threshold for cataract 
surgery to the 6/12 level 
2. to introduce special 
clauses for occupations in 
which small gains in 
binocular visual acuity can 
be essential to the ability 
to work (e.g. watchmakers, 
microsurgeons) to prevent 
inequities 
 
 
 
 
4. Discussion 
Internationally, there is a growing interest and information on geographic variations in healthcare. In a 
rising number of countries including Canada, England, Germany, Spain, the Netherlands, New Zealand 
and the United States, Atlases of Variation have either been or are being developed to raise awareness of 
regional differences in patterns of expenditure, activity and outcomes [43]. But although healthcare 
payers have unprecedented access to variations data, how to use such information to improve decisions 
about the value of resource allocation remains little understood. 
 
The findings of this study suggest some general lessons for using Atlases of Variation. First, publishing 
an Atlas of Variation may have great merit in stimulating the search and understanding of variations, 
but it may not be sufficient for achieving an impact on decision making about resource allocation. 
Generic hurdles to using research evidence – such as awareness, acceptance and perceived applicability of 
the data [12,13] – also appear to be relevant for geographic variations research. Once these barriers have 
been overcome, it appears that Atlases of Variation can serve as a “tin opener” [18] to inform strategic 
planning by healthcare payers. They may also help communicate strategic problems to clinicians. 
However, additional factors appear to be necessary for moving beyond an initial stage of gathering and 
communicating data towards subsequent stages of the decision making process where data are analysed 
and action is taken. On the one hand, decision makers will need to be able to achieve some clarity and 
consistency on the definition and operationalization of the concept of unwarranted variation. 
The current paucity of scientific frameworks identified in a recent systematic review [44] argues this 
challenge. On the other hand, agreements on responsibilities for action and leadership also appear to 
influence the uptake of variations data. Although all 53 participants in this study emphasised addressing 
unwarranted practice variations as an opportunity to reduce inappropriate use of resources within 
increasingly tight economic constraints, only 18 of 28 PCTs who had reviewed the Atlas were also able to 
coordinate further analysis and action. This is a missed opportunity. 
 
Second, who should lead in identifying and acting on variations in medical practice, and how other 
stakeholders should be involved, is increasingly becoming an issue as the public availability of 
geographic variations data continues to grow. The NHS Atlas mainly addresses commissioners 
and clinicians. Given the regionalised planning and purchasing structure, this perspective seems relatively 
straightforward for England, as the level of analysis – the Primary Care Trust – is thus consistent with the 
locus of responsibility for action. In countries with competitive social health insurance systems, in 
contrast, a regional level of analysis tends to conflict with more dispersed responsibilities for action. In 
Germany, for instance, no institutionalised bodies exist to exercise cross-sectorial planning and 
purchasing for geographically defined populations [45]. While the NHS Atlas is mainly targeted at 
health service professionals, a recently published German Atlas of Variation seeks to create pressure for 
change by targeting citizens and the wider public [46]. Further research might examine how a given 
health system context shapes the uses and users of data on variation in health service performance, and 
the respective interactions between stakeholder groups in identifying and addressing unexplained 
variations. 
 
Third, the findings also illustrate the difficult relationship between relative rates of service provision and 
appropriate provision with regard to resource allocation. The purpose of an Atlas of Variation is to reveal 
variations, and among the respondents to this study, attention logically tended to focus on the top and 
bottom outliers. The downside of stimulating action based on ‘outliers’ was some indication of false 
assurance derived from an average position. However, research does not suggest a systematic 
relationship between high, average and low rates of activity and rates of inappropriate utilisation at a 
regional level [47,48]. Simulation studies also suggest that considerable variations at lower provider 
levels of analysis may in some cases be averaged out at a higher regional level of analysis 
[49]. While an ‘outlier’ position can be a powerful trigger for further scrutiny, healthcare payers thus need 
to be wary of not conceiving the national average as an implicit reference point or even target; the danger 
is complacency. 
 
To prevent an overemphasis on individual outliers, future research may need to move from the 
measurement of single indicators towards a more systemic view of variation and its management. This 
may include not only the linkage of all three domains of quality of care – structure, process and health 
outcomes [50,51] – but also a value for money framework which relates outcomes to costs. Possible 
starting points may be the modelling of patients’ pathways across all settings of care [52,53] and, at a 
population level, explicit attention to the scale of population health gain from and expenditure on a given 
set of interventions [54]. Future research may need to focus more strongly on developing requisite models 
and designing them in such a way that they can easily be applied by health service professionals. 
 
 
5. Limitations 
This study was constrained by two main classes of limitations; those inherent to qualitative research, and 
those specific to this study. Interview-based research is well-suited to explore personal experiences and 
perceptions known only to the people involved. However, potential inaccuracies may arise due to poor 
recall and misrepresentation of facts, when respondents give answers they assume the interviewer wants 
to hear [42]. Interviews with multiple respondents per PCT, if possible, and emphasis on the open-ended, 
non-directive character of the interview questions were intended to address these challenges. A study-
specific challenge was the potential for selection bias. It remains unclear whether the non-respondents 
to this study lacked the capacity to participate in the research, in light of the large scale structural 
reorganisation of the NHS at the time of study, or whether they were not interested in the topic of 
variations in healthcare. Despite the wide spectrum of responses to the NHS Atlas illustrated in this study, 
the respondents may have been more motivated or even pioneers in engaging with geographic variations 
data compared to their peers. PCTs who reported using the NHS Atlas also tended to be of a larger size 
(responsible for populations of about 400,000–700,000, compared with the national median size of 
284,000 people [23]) or tended to be collaborating with a University. Presumably these PCTs thus had 
access to greater analytic capacity than the ‘average’ PCT. 
 
 
6. Conclusions 
Based on a case study from England, we have explored key considerations and challenges along the 
process of moving from data on geographic variations in medical practice towards decisions to improve 
the value of resource allocation. Explicit attention to these and other factors may help governments and 
payers understand the pathways through which this information might inform decision making. Our 
findings illustrate that an Atlas of Variation can support healthcare payers in framing, communicating 
and prompting the search for strategic problems, but that its mere publication may not be sufficient to 
influence decision making even in an ideal context where responsibilities for planning and purchasing 
health services across sectors are integrated in one regional organisation. The provision of appropriate 
tools to help planners understand what variation is unwarranted, and to prioritise remedial actions on 
the basis of their contribution to population health, should be a key focus for promulgators of variations 
data. 
 
 
Acknowledgements 
This research project received financial support from the NHS QIPP Right Care Programme, responsible 
for developing the NHS Atlas of Variation. Philip DaSilva is Co-Director of the NHS QIPP Right Care 
Programme and Joint-Author of the NHS Atlas of Variation. We are very grateful to all respondents from 
PCTs who invested their time and provided insight and judgement in a time of organisational turmoil in 
the NHS. We would also like to thank the Editor and two Reviewers for their helpful comments. The 
usual disclaimers apply. 
References 
[1] Wennberg JE, Gittelsohn A. Small area variations in health care delivery. Science 1973;182:1102–8. 
[2] Paul-Shaheen P, Clark JD, Williams D. Small area analysis: a review and analysis of the North American 
literature. Journal of Health Politics Policy and Law 1987;12:741–809. 
[3] McPherson K, Wennberg JE, Hovind OB, Clifford P. Small-area variations in the use of common surgical 
procedures: an international comparison of New England, England, and Norway. New England Journal of Medicine 
1982;307:1310–4. 
[4] Wennberg JE. Tracking medicine: a researcher’s quest to understand health care. New York: Oxford University; 
2010. 
[5] Evans R. The dog in the night-time. In: Andersen TV, Mooney G, editors. The challenges of medical practice 
variation. London: MacMillan; 1990. p. 117–52. 
[6] McGlynn EA. Assessing the appropriateness of care: how much is too much? Santa Monica, CA: Rand 
Corporation; 1998. 
[7] Elwyn G, Laitner S, Coulter A, Walker E, Watson P, Thomson R. Implementing shared decision making in the 
NHS. British Medical Journal 2010;341:c5146. 
[8] O’Connor A, Llewellyn-Thomas HA, Flood AB. Modifying unwarranted variations in health care: shared 
decision making using patient decision aids. Health Affairs 2004. Web exclusive: VAR63–VAR72. 
[9] Gauld R, Horwitt J, Williams S, Cohen AB. What strategies do us hospitals employ to reduce unwarranted 
clinical practice variations? American Journal of Medical Quality 2011;26:120–6. 
[10] Parente ST, Charles E, Phelps CE, O’Connor PJ. Economic analysis of medical practice variation between 1991 
and 2000: the impact of patient outcomes research teams (PORTs). International Journal of Technology Assessment 
in Health Care 2008;24:282–93. 
 [11] Wright J, Dugdale B, Hammond I, Jarman B, Neary M, Newton D, et al. Learning from death: a hospital 
mortality reduction programme. Journal of the Royal Society of Medicine 2006;99:303–8. 
[12] Glasziou P, Haynes B. The paths from research to improved health outcomes. Evidence Based Nursing 
2005;8:36–8. 
[13] Nutley SM, Walter I, Davies HTO. Using evidence: how research can 
inform public services. Bristol: The Policy Press; 2007. 
[14] Davies HTO, Lampel J. Trust in performance indicators? Quality in 
Health Care 1998;7:157–62. 
[15] Smith P. The use of performance indicators in the public sector. Journal of the Royal Statistical Society A 
1990;153:53–72. 
[16] McGlynn EA. Choosing and evaluating clinical performance measures. The Joint Commission Journal on 
Quality Improvement 1998;24:470–9. 
[17] Goddard M, Mannion R, Smith P. Assessing the performance of NHS hospital trusts: the role of ‘hard’ and 
‘soft’ data. Health Policy 1999;48:119–34. 
[18] Carter N, Klein R, Day P. How organizations measure success: the use of performance indicators in 
government. London: Routledge; 1995. 
[19] The Dartmouth Institute for Health Policy and Clinical Practice. The Dartmouth Atlas of Health Care. 
Available at:http://www.dartmouthatlas.org/ [accessed 03.01.12] 2012. 
[20] NHS Right Care. The NHS Atlas of Variation in Healthcare 2010. Available at: 
http://www.rightcare.nhs.uk/index.php/atlas/atlas-ofvariation-2010/ [accessed 04.03.12] 2010. 
[21] Grupo Atlas VPM. Atlas de Variaciones en la Práctica Médica en el Sistema Nacional De Salud n◦ 1 – n◦ 8. 
2011. Available at: http://www.atlasvpm.org/avpm/nodoUser.navegar.do?idObjeto=15&hijos= 
462&indice=1&subindice=0&marcado=1&vienede=ppal [accessed 13.12.11]. 
[22] Bogan C, English M. Benchmarking for best practices: winning through innovative adaptation. New York: 
McGraw-Hill; 1994. 
[23] Office for National Statistics. Primary Care Organisations Population Estimates (experimental) – Mid-2010. 
Available at: http://www.ons.gov.uk/ons/rel/sape/pco-pop-est-exp/mid-2010-release/pcomid-2010.html [accessed 
25.05.12]. 
[24] Boyle S. United Kingdom (England): health system review. Health Systems in Transition 2011;13:1–486. 
[25] Department of Health. PCT and SHA roles and functions. London: Department of Health; 2006. 
[26] Peskett S. The challenges of commissioning healthcare: a discussion paper. The International Journal of Health 
Planning and Management 2009;24:95–112. 
[27] Department of Health. The NHS quality, innovation, productivity and prevention challenge: an introduction for 
clinicians. London: Department of Health; 2010. 
[28] Department of Health. Equity and excellence: liberating the NHS. White Paper. London: Department of Health; 
2010. 
[29] Glover JA. The incidence of tonsillectomy in schoolchildren. Proceedings of the Royal Society of Medicine 
1938;31:1219–36. 
[30] Price CE, Paul EA, Bevan RG, Holland WW. Equity and medical practice variation: relationships between 
standardised discharge ratios in total and for selected conditions in English districts. Journal of Epidemiology and 
Community Health 1992;46:58–62. 
[31] Congdon P, Best N. Small area variation in hospital admission rates: Bayesian adjustment for primary care and 
hospital factors. Journal of the Royal Statistical Society Series C 2000;49:207–26. 
[32] Majeed A, Eliahoo J, Bardsley M, Morgan D, Bindman AB. Variation in coronary artery bypass grafting, 
angioplasty, cataract surgery, and hip replacement rates among primary care groups in London: association 
with population and practice characteristics. Journal of Public Health Medicine 2002;24:21–6. 
[33] Bevan G, Hollinghurst S, Benton P, Spark V, Sanderson H, Franklin D. Using information on variation in rates 
of supply to question professional discretion in public services. Financial Accountability and Management 
2004;20:0267–4424. 
[34] Appleby J, Raleigh V, Frosini F, Bevan G, Gao H, Lyscom T. Variations in health care. The good, the bad and 
the inexplicable. London: King’s Fund; 2011. 
[35] NHS Right Care. The NHS Atlas of Variation in Healthcare 2011. Available at: 
http://www.rightcare.nhs.uk/index.php/atlas/atlas-of-variation-2011/ [accessed 04.03.12] 2011. 
[36] Bevan G. Regulation and system management. In: Dixon A, Mays N, editors. Understanding New Labour’s 
market reforms of the English NHS. London: King’s Fund; 2011. p. 89–111. 
[37] Department of Health. The NHS Performance Framework: implementation guidance 2010/11. Available at: 
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH 115035 
[accessed 13.05.12] 2010. 
[38] Mays N. Reducing unwarranted variations in healthcare in the English NHS. British Medical Journal 
2011;342:d1849. 
[39] Boseley S. Government publishes health atlas for England. London: The Guardian; November 2010. 
[40] Jeffreys B. Variation in amputation rate ‘shocking’. London: BBC News; November 2010. 
[41] Ritchie J, Spencer L, O’Connor W. Carrying out qualitative analysis. In: Ritchie J, Lewis J, editors. Qualitative 
research practice: a guide for social science students and researchers. London: Sage; 2003. 
[42] Robson C. Real world research: a resource for users of social research methods in applied settings. Chichester: 
Wiley; 2011. 
[43] Right Care. International Atlases. London: NHS Right Care. Available at: 
http://www.rightcare.nhs.uk/index.php/tools-resources/international-atlases/ [accessed 04.03.12] 2012. 
[44] Mercuri M, Gafni A. Medical practice variations: what the literature tells us (or does not) about what are 
warranted and unwarranted variations. Journal of Evaluation in Clinical Practice 2011;17: 671–7. 
[45] Ettelt S, Fazekas M, Mays N, Nolte E. Assessing health care planning –a framework-led comparison of 
Germany and New Zealand. Health Policy 2012;106:50–9. 
[46] Nolting H, Zich K, Deckenbach B, Gottberg A, Lottmann K, Klemperer D, et al. Faktencheck Gesundheit. 
Regionale Unterschiede in der Gesundheitsversorgung. Gütersloh: Bertelsmann Stiftung; 2011. 
[47] Leape LL, Park RE, Solomon DH, Chassin MR, Kosecoff J, Brook RH. Does inappropriate use explain small-
area variations in the use of health-care services? Journal of the American Medical Association 1990;263:669–72. 
[48] Chassin MR, Kosecoff J, Park RE, Winslow CM, Kahn KL, Merrick NJ, et al. Does inappropriate use explain 
geographic variations in the use of health-care services – a study of 3 procedures. Journal of the American Medical 
Association 1987;258:2533–7.  
[49] Diehr P, Cain K, Connell F, Volinn E. What is too much variation? The null hypothesis in small-area analysis. 
Health Services Research 1990;24:741–71. 
[50] Donabedian A. The quality of medical care. Science 1978;200:856–64. 
[51] Donabedian A. Evaluating the quality of medical care, 1966. Milbank Quarterly 2005;83:691–729. 
[52] Porter M. What is value in health care? New England Journal of Medicine 2010;363:2477–81. 
[53] Porter M, Teisberg E. Redefining health care: creating value-based competition on results. Boston, MA: 
Harvard Business School Press; 2006. 
[54] Bevan G, Airoldi M, Morton A, Oliveira M, Smith J. Estimating health and productivity gains in England from 
selected interventions. London: The Health Foundation; 2007. 
